Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 



 

 
HOME >> PRODUCTS >> Taj Products >> PDF Download
Taj  ALL Products View Products According to Category


Read the information for this product.

 
Read the Indian physician prescribing information for this medication. (PDF)


 

cocorex


If you do not have the Acrobat Reader installed on your computer, download the plug-in and simply follow the instructions for installation. It is available without charge from Adobe®.com.

This link is provided as a convenience. Taj Pharma is not responsible for the content of this linked page.



 

Note : This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.
Information for Health Care Professionals
*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).
SCHEDULE IV CONTROLLED SUBSTANCES : Controlled Substances Import and Export Act
TITLE 21 - FOOD AND DRUGS
CHAPTER 13 - DRUG ABUSE PREVENTION AND CONTROL
SUBCHAPTER II - IMPORT AND EXPORT
"Placement on schedules; findings required Schedule IV substances are those that have the following findings:The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule III. The drug or other substance has a currently accepted medical use in treatment in the United StatesAbuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III.Control measures are similar to Schedule III. Prescriptions for Schedule IV drugs may be refilled up to five times within a six-month period. A prescription for controlled substances in Schedules III, IV, and V issued by a practitioner, may be communicated either orally, in writing, or by facsimile to the pharmacist, and may be refilled if so authorized on the prescription or by call-in. DRUGS IN THIS SCHEDULE INCLUDE:Benzodiazepines, such as ALPRAZOLAM (Xanax), chlordiazepoxide (Librium), clonazepam (Klonopin), diazepam (Valium), and Lorazepam (Ativan), as well as:temazepam (Restoril) (note that some states require specially coded prescriptions for temazepam) flunitrazepam (Rohypnol) (note that flunitrazepam is not used medically in the United States). The benzodiazepine-like Z-drugs: zolpidem (Ambien), zopiclone (Imovane), eszopiclone (Lunesta), and zaleplon (Sonata) (zopiclone is not commercially available in the U.S.) Chloral hydrate, a sedative-hypnotic, Long-acting barbiturates such as phenobarbitalSome partial agonist opioid analgesics, such as pentazocine (Talwin) The stimulant-like drug modafinil (sold in the U.S. as Provigil) as well as its (R)-enantiomer armodafinil (sold in the U.S. as Nuvigil)
Difenoxin, an antidiarrheal drug, such as when combined with atropine (Motofen) (difenoxin is 2–3 times more potent than diphenoxylate, the active ingredient in Lomotil, which is in Schedule V)
Tramadol (Ultram) / Carisoprodol (Soma) has become a Schedule IV medication as of 11 January 2012.
Section 1000 [951 note] Short Title
This title may be cited as the "Controlled Substances Import and Export Act.'' EXPORT IS SUBJECTED TO NOC (Narcotic Drugs Import and Export Act) INDIA.
Export/ Import
ANY NARCOTIC DRUGS OR PSYCHOTROPIC SUBSTANCES CAN BE IMPORTED INTO/ EXPORTED OUT OF INDIA SUBJECT TO RULE 53 AND RULE 53-A OF THE NDPS RULES, 1985.
The import of - (i) opium, concentrate of poppy straw, and (ii) morphine, codeine, thebaine, and their salts is prohibited save by the Government Opium Factory under the provision of Rule 54 of the NDPS Rules, 1985. The import into and export out of India of any narcotic drugs or psychotropic substances specified in Schedule I  is prohibited under the provision of Rule 53 of the NDPS Rules, 1985. The export of any narcotic drugs or psychotropic substances or preparations containing any of such narcotic drugs or psychotropic substances specified in Schedule II  shall be prohibited to the countries or to the region of such country specified therein under the provision of Rule 53-A of the NDPS Rules, 1985.The manufacture of psychotropic substances specified in Schedule III  can be allowed for export purpose only under the provision of Rule 65(1) of the NDPS Rules, 1985. The import of psychotropic substances specified in Schedule III may be allowed for test/ analysis purpose as well as for re-export purpose. The export out of / import into India of a select number of Precursor Chemicals  is exercised by the Narcotics Commissioner in accordance with Directorate General of Foreign Trade (DGFT) notification  and Administrative Control.
ANY COMPANY/APPLICANT DESIROUS OF OBTAINING NO OBJECTION CERTIFICATE FOR EXPORT OF NOTIFIED PRECURSOR CHEMICALS ARE  REQUIRED TO APPLY TO THE NARCOTICS COMMISSIONER. (UNDER RULES FROM CENTRAL BUREAU OF NARCOTICS, GOVERNMENT OF INDIA)

 

 

 

 

 

 

 

 


 






 


 

 

 

 

 

 

 

 

 



 


              
 Print page   Send by mail


 



 

   
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 www.tajpharma.com

   

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement